Nephrodi Therapeutics

Developer of therapeutics for concentration disorders of the kidney

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2017 groups5 employees language nephrodi.com

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace slowing. Cited 54 times.

YearFilings
20201
20211
20221
20231
20241
20251

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Accelerator & incubator133%
Other / undisclosed133%
Coming soon